shortagewatch

Home / Lacosamide / Italy

IT ATC N03AX18 · updated 2 Nov 2026

Lacosamide shortage in Italy

Is there a Lacosamide shortage in Italy?

Yes. As of 2 Nov 2026, 15 Lacosamide products are reported short in Italy, the first since 7 Aug 2023. No return date has been given. Main reason: increased demand.

Also short in Canada, Spain, Czechia, Sweden, Australia. All countries.

Affected products in Italy

CountryProductCompanySinceExpected backReason
ITLACOSAMIDE ZENTIVAZENTIVA ITALIA S.R.L.7 Aug 2023not givenManufacturing problem
Problemi produttivi
ITLACOSAMIDE ZENTIVAZENTIVA ITALIA S.R.L.1 Mar 2025not givenManufacturing problem
Problemi produttivi
ITLACOSAMIDE ACCORDACCORD HEALTHCARE, S.L.U.17 Sep 2025not givenIncreased demand
Elevata richiesta
ITLACOSAMIDE ACCORDACCORD HEALTHCARE, S.L.U.26 Feb 2026not givenIncreased demand
Elevata richiesta
ITLACOSAMIDE SANDOZSANDOZ S.P.A.1 Mar 2026not givenManufacturing problem
Problemi produttivi
ITLACOSAMIDE ACCORDACCORD HEALTHCARE, S.L.U.24 Apr 2026not givenIncreased demand
Elevata richiesta
ITLACOSAMIDE ACCORDACCORD HEALTHCARE, S.L.U.24 Apr 2026not givenIncreased demand
Elevata richiesta
ITLACOSAMIDE ACCORDACCORD HEALTHCARE, S.L.U.24 Apr 2026not givenIncreased demand
Elevata richiesta/problemi produttivi
ITLACOSAMIDE ACCORDACCORD HEALTHCARE, S.L.U.24 Apr 2026not givenIncreased demand
Elevata richiesta
ITLACOSAMIDE ZENTIVAZENTIVA ITALIA S.R.L.30 Apr 2026not givenManufacturing problem
Problemi produttivi
ITLACOSAMIDE ZENTIVAZENTIVA ITALIA S.R.L.5 Jun 2026not givenManufacturing problem
Problemi produttivi
ITLACOSAMIDE ZENTIVAZENTIVA ITALIA S.R.L.5 Jun 2026not givenManufacturing problem
Problemi produttivi
ITLACOSAMIDE ZENTIVAZENTIVA ITALIA S.R.L.5 Jun 2026not givenIncreased demand
Elevata richiesta/problemi produttivi
ITLACOSAMIDE MYLANMYLAN S.P.A.20 Jun 2026not givenIncreased demand
Elevata richiesta/problemi produttivi
ITLACOSAMIDE TECNIGENTECNIGEN S.R.L.21 Sep 2026not givenIncreased demand
Elevata richiesta

Source

AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.